Opioid Receptor Antagonists in Psychiatry: Beyond Drug Addiction

Author： Rénéric J-P.   Bouvard M.P.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.10, Iss.5, 1998-11, pp. : 365-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Endogenous Mu- and Delta-Opioid Receptor Systems for the Treatment of Drug Addiction

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 5, 2008-11 ,pp. : 442-453

Bentham Science Publishers

Access to resources Recommend Favorite

Ultraselective antagonists of the d-opioid receptor

By Lazarus L.H.   Salvadori S.   Temussi P.A.   Balboni G.   Guerrini R.   Bryant S.D.   Cooper P.S.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 45-47

Informa Healthcare

Access to resources Recommend Favorite

Oxycodone combined with opioid receptor antagonists: efficacy and safety

By Davis Mellar   Goforth Harold W   Gamier Pam  

Expert Opinion on Drug Safety, Vol. 12, Iss. 3, 2013-05 ,pp. : 389-402

Informa Healthcare

Access to resources Recommend Favorite

Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential

By Herpfer Inga   Lieb Klaus  

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 275-293

Adis International

Access to resources Recommend Favorite

14 -Chlorocinnamoylamino derivatives of metopon: long-term -opioid receptor antagonists

By McLaughlin J.P.   Sebastian A.   Archer S.   Bidlack J.M.  

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 121-129

Elsevier

Access to resources Recommend Favorite